Search

everythinglearnresearchcommunity

for

Search:↓

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

Biomedical imaging has greatly improved understanding and treatment of solid tumors.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

Mutant stem cells adapt their metabolism differently to outcompete normal cells in the skin.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Cancer prevention is crucial, with a focus on research and improved screening methods.

The research shows that skin cancer likely originates from hair follicles and that certain cell populations expand to promote skin cancer growth.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

The cancer gene c-Myc increases harmful chemicals that damage DNA and can lead to cancer, but antioxidants can reduce this damage.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Living near more dermatologists and using certain cancer screening tests lowers the chance of being diagnosed with advanced skin cancer.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Early-onset colorectal cancer requires better physician awareness, risk-based screening, and stigma reduction to improve patient experiences.